Analysen von Richard Vosser
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 18.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 15.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 03.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 03.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 08.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.04.19 | Roche overweight | JP Morgan Chase & Co. | |
| 02.04.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.03.19 | Roche overweight | JP Morgan Chase & Co. | |
| 20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.02.19 | Roche overweight | JP Morgan Chase & Co. | |
| 04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.01.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.01.19 | Roche overweight | JP Morgan Chase & Co. | |
| 02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.01.19 | Roche overweight | JP Morgan Chase & Co. | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.01.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 06.12.18 | Bayer overweight | JP Morgan Chase & Co. | |
| 05.12.18 | Roche overweight | JP Morgan Chase & Co. | |
| 03.12.18 | Roche overweight | JP Morgan Chase & Co. | |
| 29.11.18 | Bayer overweight | JP Morgan Chase & Co. | |
| 23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.11.18 | Bayer overweight | JP Morgan Chase & Co. | |
| 13.11.18 | Bayer overweight | JP Morgan Chase & Co. | |
| 05.11.18 | Bayer overweight | JP Morgan Chase & Co. | |
| 02.11.18 | Bayer overweight | JP Morgan Chase & Co. | |
| 02.11.18 | Roche overweight | JP Morgan Chase & Co. | |